SPAC5D6.04 Antibody

Shipped with Ice Packs
In Stock

Description

Gene Overview

The SPAC5D6.04 gene encodes a protein involved in GPI (glycosylphosphatidylinositol) anchoring and cell wall biogenesis in S. pombe. It belongs to the auxin family of proteins, which are critical for modifying cell wall components during growth and septation . GPI-anchored proteins are covalently linked to the cell wall matrix, contributing to structural integrity and surface antigen presentation .

Antigen and Antibody Specificity

The SPAC5D6.04 antibody targets the gene product of SPAC5D6.04, which is implicated in septum formation and cell wall material deposition. Experimental studies using anti-α-tubulin and anti-HA antibodies (commonly used in S. pombe research) have shown that SPAC5D6.04 interacts with β-1,3-glucan synthesis enzymes, such as Gas2p, during septum closure . The antibody is likely used in Western blotting, immunoprecipitation, or fluorescence microscopy to monitor protein localization and post-translational modifications.

Applications in Research

ApplicationMethodKey Findings
Cell wall analysisWestern blottingDetection of hypo-mannosylated SPAC5D6.04 in O-mannosylation-deficient mutants
Septum formationImmunofluorescenceLocalization of SPAC5D6.04 to septum material during cell division
Protein interactionsCo-IP (co-immunoprecipitation)Interaction with Gas2p (β-1,3-glucanosyltransferase)

Experimental Validation

  • Expression Analysis: The SPAC5D6.04 gene is essential for cell viability, as its deletion leads to defects in septum assembly .

  • Protein Modifications: In oma4Δ mutants (defective in O-mannosylation), SPAC5D6.04 undergoes N-glycosylation at an unusual N-X-A sequon, suggesting adaptive post-translational regulation .

Research Context

The SPAC5D6.04 antibody is primarily used in academic studies of yeast cell biology. While commercial availability is not explicitly documented, its production likely involves standard monoclonal or polyclonal strategies, such as immunizing mice with recombinant SPAC5D6.04 protein or peptides . Cross-reactivity with other GPI-anchored proteins has not been reported, indicating high specificity.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC5D6.04; Uncharacterized transporter C5D6.04
Target Names
SPAC5D6.04
Uniprot No.

Target Background

Database Links
Protein Families
Auxin efflux carrier (TC 2.A.69) family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is SPAC5D6.04 and why is it important in S. pombe research?

SPAC5D6.04 is a gene in Schizosaccharomyces pombe (fission yeast) that belongs to the auxin family proteins . These proteins are significant in cell wall development and maintenance in yeast species. Based on homology studies and functional analyses, SPAC5D6.04 may be involved in processes related to cell wall integrity, potentially similar to other proteins that participate in glucan synthesis and modification. The investigation of SPAC5D6.04 is particularly valuable for understanding fundamental cellular processes in eukaryotic organisms, as S. pombe serves as an excellent model organism with conserved pathways relevant to higher eukaryotes.

How are antibodies against SPAC5D6.04 typically generated?

Antibodies against SPAC5D6.04 are typically generated using recombinant protein expression systems. The process generally involves:

  • Cloning the SPAC5D6.04 gene or specific epitope-containing fragments into an expression vector

  • Expressing the protein in a heterologous system (E. coli, mammalian cells, or insect cells)

  • Purifying the recombinant protein using affinity tags

  • Immunizing animals (typically rabbits or mice) with the purified protein

  • Collecting and purifying the resulting antibodies

For more specific applications, techniques similar to the affinity purification methods described for other yeast proteins can be employed . This includes using GST-fusion peptides of the target protein for generating and purifying polyclonal antibodies, which can significantly improve specificity and reduce background in experimental applications.

What validation methods are essential for confirming SPAC5D6.04 antibody specificity?

When validating SPAC5D6.04 antibodies, researchers should employ multiple complementary approaches:

Validation MethodApplicationExpected Outcome
Western blot with knockout/knockdown controlsProtein expression analysisSingle band at expected MW in WT, absent/reduced in KO/KD
Immunoprecipitation followed by mass spectrometryVerification of binding targetsSPAC5D6.04 should be the predominant protein identified
Peptide competition assayEpitope specificity confirmationSignal should be blocked by pre-incubation with immunizing peptide
Cell staining pattern comparisonLocalization validationPattern should match known localization and be absent in KO

Similar to validation approaches used for other specific antibodies in yeast research, these methods ensure that the antibody specifically recognizes SPAC5D6.04 and not related proteins . In particular, the proteinase K protection assay methodology described for yeast proteins can be adapted to validate membrane topology predictions for SPAC5D6.04 .

How can SPAC5D6.04 antibodies be used to study protein-protein interactions in the context of cell wall integrity?

SPAC5D6.04 antibodies can be instrumental in characterizing protein-protein interactions within the cell wall integrity network through several advanced approaches:

  • Co-immunoprecipitation (Co-IP) followed by mass spectrometry to identify novel interaction partners

  • Proximity-dependent biotin identification (BioID) using SPAC5D6.04 as bait

  • Fluorescence resonance energy transfer (FRET) analysis with fluorophore-conjugated antibodies

  • Chromatin immunoprecipitation (ChIP) if SPAC5D6.04 has nuclear functions

Drawing from techniques similar to those used for other yeast cell wall proteins, researchers can employ cell wall biotinylation methods to study SPAC5D6.04 surface exposure and interactions . Furthermore, when analyzing protein complexes containing SPAC5D6.04, it's crucial to optimize extraction conditions that preserve native interactions while effectively solubilizing membrane-associated proteins, potentially using approaches similar to those employed for Sup11p characterization studies .

What considerations are important when using SPAC5D6.04 antibodies for localization studies during cell cycle progression?

When conducting localization studies of SPAC5D6.04 across the cell cycle, researchers should consider:

  • Synchronization methods that minimally perturb cell wall dynamics

  • Fixation protocols that preserve both antigenicity and cell morphology

  • Co-staining with cell cycle markers (e.g., septum-specific dyes or α-tubulin antibodies)

  • Live-cell imaging with fluorophore-conjugated antibody fragments

Cell cycle studies require careful timing and synchronization. Similar to approaches used for studying septum assembly proteins in S. pombe, researchers should consider employing temperature-sensitive cell division cycle mutants or chemical synchronization methods that don't interfere with cell wall integrity . Additionally, when examining SPAC5D6.04 localization at the septum, researchers may benefit from correlating their findings with known septum assembly and separation markers, as detailed in studies of S. pombe cell division .

How do post-translational modifications affect SPAC5D6.04 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of SPAC5D6.04, particularly:

Modification TypePotential Impact on Antibody RecognitionDetection Solution
GlycosylationMay mask epitopes or create steric hindranceUse deglycosylating enzymes (e.g., EndoH) before detection
PhosphorylationMay alter epitope conformationUse phospho-specific antibodies for modified forms
GPI-anchoringMay affect C-terminal epitope accessibilityTarget N-terminal epitopes for detection
Proteolytic processingMay result in unexpected fragment sizesUse antibodies targeting different regions of the protein

Studies of protein glycosylation in fission yeast indicate that O-mannosylation and N-glycosylation can significantly alter protein recognition by antibodies . For instance, hypo-mannosylated proteins may display different migration patterns in SDS-PAGE and altered antibody recognition compared to their fully glycosylated counterparts, as observed with Sup11p:HA when expressed in O-mannosylation mutant backgrounds .

What are the optimal sample preparation protocols for detecting SPAC5D6.04 in different subcellular fractions?

Effective detection of SPAC5D6.04 across different subcellular compartments requires specialized extraction and preparation methods:

  • For membrane-associated SPAC5D6.04:

    • Spheroplasting of S. pombe using standardized protocols (e.g., zymolyase treatment)

    • Gentle lysis in non-ionic detergent buffers (e.g., 1% Triton X-100)

    • Differential centrifugation to separate membrane fractions

  • For cell wall-incorporated SPAC5D6.04:

    • Extraction with hot SDS followed by β-1,3-glucanase treatment

    • Analysis of release patterns to determine linkage to cell wall components

  • For soluble fractions:

    • Standard TCA precipitation or native extraction in physiological buffers

These approaches can be modeled after protocols used for extracting and analyzing other S. pombe cell wall and membrane proteins . Particularly, the spheroblasting procedures detailed for S. pombe can be directly applied when isolating membrane fractions containing SPAC5D6.04 .

How should western blot conditions be optimized for SPAC5D6.04 detection?

Optimizing western blot conditions for SPAC5D6.04 detection requires attention to several key parameters:

ParameterRecommended ConditionRationale
Sample bufferInclude reducing agents (DTT/BME)Breaks disulfide bonds that may mask epitopes
Gel percentage10-12% for full-length; 15% for fragmentsBalances resolution and transfer efficiency
Transfer methodWet transfer at lower voltage (30V) overnightImproves transfer of membrane proteins
Blocking solution5% non-fat milk in TBSTReduces background without interfering with most epitopes
Primary antibody dilutionStart at 1:1000, optimize as neededBalance between signal strength and background
Secondary antibodyHRP or fluorophore-conjugatedSelect based on desired detection method
VisualizationECL for HRP; fluorescence imaging for fluorophoresMatch detection method to antibody system

Following protocols similar to those employed for other membrane proteins in yeast studies, researchers should consider including both positive controls (tagged SPAC5D6.04 overexpression) and negative controls (SPAC5D6.04 deletion strains) in their western blot experiments . Additionally, when analyzing glycosylated forms of SPAC5D6.04, EndoH treatment protocols can be employed to distinguish between different glycoforms, similar to approaches used for other glycoproteins in S. pombe .

What approaches can overcome epitope masking issues when using SPAC5D6.04 antibodies?

Epitope masking can significantly impair SPAC5D6.04 detection, particularly if the protein forms complexes or undergoes conformational changes. Effective strategies include:

  • Epitope retrieval techniques:

    • Heat-mediated retrieval in citrate buffer (pH 6.0)

    • Enzymatic retrieval using proteases at controlled concentrations

    • Detergent-based unmasking with SDS followed by quenching

  • Alternative fixation methods:

    • Test multiple fixatives (PFA, methanol, acetone)

    • Optimize fixation duration and temperature

    • Evaluate dual fixation protocols

  • Sample treatment approaches:

    • Denaturation conditions that expose hidden epitopes

    • Limiting cross-linking to preserve antibody accessibility

For cell wall-associated proteins like SPAC5D6.04, researchers may encounter masking due to cell wall polysaccharides. In such cases, limited enzymatic digestion with cell wall-degrading enzymes prior to immunostaining can improve epitope accessibility while preserving cellular architecture, similar to approaches used in studies of other cell wall proteins in yeast .

How can researchers address non-specific binding when using SPAC5D6.04 antibodies in immunoprecipitation?

Non-specific binding in SPAC5D6.04 immunoprecipitation experiments can be minimized through several approaches:

  • Pre-clearing lysates with the same beads used for immunoprecipitation

  • Including competing proteins (BSA, gelatin) in wash buffers

  • Using denaturing conditions for initial extraction followed by dilution

  • Employing tagged versions of SPAC5D6.04 with high-affinity purification systems

Affinity purification of antibodies against SPAC5D6.04 can significantly reduce non-specific binding. Similar to methods described for purifying antibodies against GST-fusion peptides of yeast proteins, researchers can employ antigen-specific purification approaches to isolate the most specific antibody populations from polyclonal sera .

What strategies help resolve discrepancies between different antibody-based detection methods for SPAC5D6.04?

When encountering discrepancies between detection methods (e.g., western blot vs. immunofluorescence), researchers should:

  • Evaluate epitope accessibility in different experimental contexts

  • Consider native vs. denatured protein conformations

  • Assess the impact of sample preparation on SPAC5D6.04 structure

  • Test antibodies targeting different epitopes of SPAC5D6.04

  • Implement orthogonal detection methods (mass spectrometry, activity assays)

Cross-validation using multiple detection methods is essential for accurate interpretation. Researchers can employ approaches similar to those used for validating other yeast proteins, including combinations of biochemical fractionation, immunodetection, and functional assays . Additionally, transcriptome analysis can provide complementary evidence of SPAC5D6.04 expression patterns in different conditions, similar to transcriptomic approaches used for analyzing other S. pombe genes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.